This inventor holds 1 USPTO granted patent. Top assignee: Konkuk University. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Min-chul Cho: Innovator in Monoclonal Antibodies
Introduction
Min-chul Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on interleukin-32, a cytokine involved in various immune responses.
Latest Patents
Min-chul Cho holds a patent for "IL-32 monoclonal antibodies and uses thereof." This invention provides monoclonal antibodies that are specific for interleukin-32 (IL-32), previously referred to as 'natural killer cell transcript 4' or 'NK4.' The patent also includes hybridomas that secrete these specific monoclonal antibodies. Additionally, it outlines diagnostic methods and kits, such as ELISA and Western blot, that utilize these antibodies.
Career Highlights
Min-chul Cho is affiliated with Konkuk University, where he continues to advance research in immunology and biotechnology. His innovative work has garnered attention in the scientific community, contributing to the understanding of immune responses and potential therapeutic applications.
Collaborations
Some of his notable coworkers include Jung-Woo Kang and Eun-Hee Seo, who have collaborated with him on various research projects. Their combined expertise enhances the research output and innovation at Konkuk University.
Conclusion
Min-chul Cho's contributions to the field of monoclonal antibodies represent a significant advancement in biotechnology. His patent on IL-32 monoclonal antibodies showcases his innovative spirit and dedication to improving diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile